Home/Filings/4/0001140361-21-020649
4//SEC Filing

Agresta Samuel 4

Accession 0001140361-21-020649

CIK 0001113148other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:16 PM ET

Size

5.2 KB

Accession

0001140361-21-020649

Insider Transaction Report

Form 4
Period: 2021-06-10
Agresta Samuel
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-10+30,00030,000 total
    Exercise: $3.43Exp: 2031-06-09Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.

Issuer

INFINITY PHARMACEUTICALS, INC.

CIK 0001113148

Entity typeother

Related Parties

1
  • filerCIK 0001748961

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:16 PM ET
Size
5.2 KB